Eosinophilic pleural effusion and stroke with cutaneous vasculitis: Two cases of dupilumab‐induced hypereosinophilia

Efficacy and Safety of treatment with biologicals for severe Chronic Rhinosinusitis with Nasal Polyps A systematic review for the EAACI Guidelines

(2021) Ioana Agache et al.   ALLERGY

Dupilumab‐associated hypereosinophilia in patients treated for moderate‐to‐severe atopic dermatitis

(2021) P. Marcant et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Effectiveness and safety of dupilumab for the treatment of severe asthma in a real‐life French multi‐centre adult cohort

(2020) Clairelyne Dupin et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Dupilumab for Atopic Dermatitis, a Possible Risk Factor of Juvenile Ischemic Stroke: A Case Report

(2020) Ryo Iwase et al.   Journal of Stroke & Cerebrovascular Diseases

Immune Modulation in Asthma: Current Concepts and Future Strategies

(2020) Marek Lommatzsch   RESPIRATION

Dupilumab is effective in type 2‐high asthma patients receiving high‐dose inhaled corticosteroids at baseline

(2020) Arnaud Bourdin et al.   ALLERGY

A case of chronic eosinophilic pneumonia in a patient treated with dupilumab

(2019) Francesco Menzella et al.   Therapeutics and Clinical Risk Management

Spectrum of Eosinophilic End-Organ Manifestations

(2015) Praveen Akuthota et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA